Ultragenyx Pharmaceutical Inc - ESG Rating & Company Profile powered by AI
Detailed Sustainability analysis of Ultragenyx Pharmaceutical Inc can be reached by signing in. Alternative corporations in the scoring peer group for Ultragenyx Pharmaceutical Inc are displayed. The Disclosure rating includes seventeen United Nations SDGs including: 'No Poverty', 'Climate Action' and 'Partnerships for the Goals'.
Ultragenyx Pharmaceutical Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 7.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Ultragenyx Pharmaceutical Inc | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ultragenyx Pharmaceutical Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc report the average age of the workforce?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc offer flexible work?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc conduct supply chain audits?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose water use targets?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ultragenyx Pharmaceutical Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ultragenyx Pharmaceutical Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ultragenyx Pharmaceutical Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose its waste policy?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose energy use targets?
Sign up for free to unlockDoes Ultragenyx Pharmaceutical Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ultragenyx Pharmaceutical Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ultragenyx Pharmaceutical Inc
These potential risks are based on the size, segment and geographies of the company.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc.; and Daiichi Sankyo Co., Ltd. Ultragenyx Pharmaceutical Inc. was incorporated in 2010 and is headquartered in Novato, California.